Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | NNRTI used in first-line HIV regimens, with vivid dreams as a common side effect. | Backbone drug for HIV treatment, PrEP and hepatitis B. |
| Body system | Antivirals | Antivirals |
| Drug class | Non-nucleoside reverse transcriptase inhibitors | Nucleos(t)ide reverse transcriptase inhibitors |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | HIV infection (with other drugs) | HIV treatment, HIV pre-exposure prophylaxis (PrEP, with emtricitabine), Chronic hepatitis B |
| How it works | Blocks HIV from copying itself. | A fake DNA building block that stops HIV and hepatitis B copying themselves. |
| Starts working | Weeks | — |
| Half-life | 40–55 hours | About 17 hours in plasma |
| Typical adult dose | 600 mg once a day at bedtime. | 300 mg (245 mg tenofovir disoproxil) once a day. |
| Forms | Tablet, Combination tablets | Tablet, Combination tablets |
| Common side effects | Vivid dreams, Dizziness, Rash, Insomnia, Difficulty concentrating | Nausea, Diarrhoea, Headache, Dizziness |
| Serious side effects | Depression and suicidal thoughts, Liver injury, Severe skin reactions, QT prolongation | Kidney damage, Bone thinning, Hepatitis B flare if stopped suddenly |
| Don't take if | Severe liver disease; Depression with suicidal thoughts; First trimester without alternatives | — |
| Alcohol | Best avoided. Alcohol adds to dizziness and liver stress. | — |
| Pregnancy | Use with cautionConsidered safe after the first trimester; contraception is advised. | Generally considered safeWidely used in pregnancy for HIV and hepatitis B. |
| Breastfeeding | Usually avoidedNot recommended where safe formula is available. | — |
| In use since | — | 2001 |
| Brand names | United States: Sustiva, Atripla (combination)United Kingdom: SustivaIndia: Efavir, Viranz | United States: Viread, Truvada (with emtricitabine)United Kingdom: Viread, TruvadaIndia: Tenvir |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | J05AG03 | J05AF07 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker